Are breast and prostate cancers wildly overdiagnosed? Is it becoming a crass industry rather than honest medical science?
- 1 people answered
Edit Tags
Tags are used to find the best answers
You might also be interested in
When you think about breast cancer, what do you think of? A young woman with nipple discharge? Probably not. And that's because we often associate a lump as a sign of breast cancer, as well as assuming it only affects older women. But what about the other symptoms? There are some lesser known ind....
It might depend on the cancer. Stage I breast cancer is the earliest stage of invasive breast cancer. At this stage, the cancer cells have spread beyond the original location and into the surrounding breast tissue. Because a stage I tumor is small, it may be difficult to detect. However, breast s....
Please mention if it is around the nipple area as well and with/without discharge. What kind of pain is it? Does it occur during your periods? Once I know answers to these, I would be able to guide you better.
Credihealth is not a medical practitioner and does not provide medical advice. You should consult your doctor or with a healthcare professional before starting any diet, exercise, supplementation or medication program. Know More
लेखक:Dr. Nitika Sharma - BDS
समीक्षा की गई:Dr. Rakesh Kumar - MBBS, MS
Deepak Kumar
It depends on the country. Overdiagnosis relates to the finding of a cancer that doesn’t act in a life-limiting way. Since the beginning of mammography and PSA eras we have diagnosed a lot of such disease.Mammography has not changed the percentage of women who have metastatic disease, rather it has increased the diagnosis of breast cancer enormously with many, many of these not a threat to life.With respect to PSA screening it’s not clear at all whether it saves lives, either. But such screening increases the number of patients diagnosed and treated for non-disease.But the problem is that up to now we haven’t been able to distinguish disease from non-disease very well so we treat people to be sure. But we’re entering into the era of personalised medicine.
Recently an excellent paper was published showing the size of a breast tumour does not signal malignant behaviour nearly as much as its genetic makeup.